OPTIQGAIN LTD

Their core work

OPTIQGAIN LTD is an Israeli technology SME that develops high-resolution, real-time molecular analysers for industrial process control. Their core product, SRSensor, is an inline or near-line instrument capable of identifying and quantifying molecular composition in manufacturing or industrial environments as processes run. They successfully navigated the full EU SME Instrument pathway — from feasibility (Phase 1) to funded commercialisation (Phase 2) — demonstrating that their technology reached a level of maturity attractive to EU evaluators. Their work sits at the intersection of optical sensing, spectroscopy, and industrial automation.

What they specialise in

How they've shifted over time

OPTIQGAIN's H2020 activity covers only 2018–2022 and is built entirely around a single product line, SRSensor, with no detectable shift in research direction. The Phase 1 project in 2018 was a short feasibility study to validate the concept; the Phase 2 project starting in 2019 represents the full development and market-entry push with substantially larger funding. There is no evidence of diversification — their trajectory is one of deepening focus on the same technology rather than broadening into new domains.

OPTIQGAIN appears to be a single-product company on a commercialisation path; a future collaborator would most likely engage them as a technology supplier or sensing component provider rather than as a research partner exploring new domains.

How they like to work

OPTIQGAIN has acted exclusively as project coordinator in both H2020 projects, with zero recorded consortium partners — a profile typical of SME Instrument grants, which are designed for solo companies rather than collaborative consortia. This means there is no evidence of how they behave within multi-partner projects, and any assumption about collaborative working style would be speculative. If you are building a consortium and want them as a technology provider, expect to initiate the relationship rather than find them already embedded in a network.

OPTIQGAIN has no recorded EU consortium partners across its two H2020 projects, which reflects the solo-applicant nature of the SME Instrument scheme rather than isolation by choice. Their network within the EU research ecosystem is effectively unmapped from public data.

What sets them apart

OPTIQGAIN is one of a small number of Israeli SMEs that completed the full SME Instrument Phase 1 → Phase 2 journey, suggesting their technology passed rigorous EU commercial-readiness evaluation twice. Their focus on molecular analysis for industrial process control targets a specific and high-value gap: manufacturers who need molecular-level insight without sending samples to a lab. If the SRSensor technology performs as described, it addresses a real operational bottleneck in process industries where batch testing introduces lag and cost.

Highlights from their portfolio

• SRSensor (Phase 2)
  The largest funded project at €1,788,682 represents a full EU-backed commercialisation push for an industrial molecular analyser, running 2019–2022 — the company's primary vehicle for bringing its product to market.
• SRSensor (Phase 1)
  The Phase 1 feasibility award in 2018 validated the SRSensor concept to EU evaluators and directly unlocked the larger Phase 2 grant, making it the foundation of the entire funding story.